Video

Shift to Performance-Based Reimbursement Presents Opportunities for Pharmacies

Marci Strauss, PharmD, discussed how pharmacists are reacting to the ongoing shift toward performance-based reimbursement models.

In an interview at PDS 2022, Marci Strauss, PharmD, discussed how pharmacists are reacting to the ongoing shift toward performance-based reimbursement models.

Strauss discussed common challenges associated with reimbursement, the shift to a performance-based model, her work on the PDS program tackling performance-based reimbursement, and where she expects to see all of these issues heading in the future. Regardless of where reimbursement models go, Strauss said remaining ahead of the curve is essential for independent pharmacies.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Image credit: Sebastian Kaulitzki | stock.adobe.com
Magnified bone marrow biopsy showing plasma cells with irregular nuclei and multiple myeloma tumor cells infiltrating normal hematopoietic tissue
Health and nutrition: the role of glp-1 in diabetes management with apple and syringe - Image credit: Thanayut | stock.adobe.com